牛牛AI助理已提取核心訊息
Jerrold Sendrow, a reporting person for Virpax Pharmaceuticals, Inc. [VRPX], has engaged in a transaction involving the company's stock. The action took place on January 29, 2024. However, the details regarding the nature of the transaction, such as the action type, status, number of shares involved, transaction price, and the resulting ownership stake, have not been disclosed in the announcement. Investors are advised to seek additional information to fully understand the implications of this transaction on their investment decisions.
Jerrold Sendrow, a reporting person for Virpax Pharmaceuticals, Inc. [VRPX], has engaged in a transaction involving the company's stock. The action took place on January 29, 2024. However, the details regarding the nature of the transaction, such as the action type, status, number of shares involved, transaction price, and the resulting ownership stake, have not been disclosed in the announcement. Investors are advised to seek additional information to fully understand the implications of this transaction on their investment decisions.
Virpax Pharmicals, Inc. [VRPX] 的舉報人傑羅德·森德羅參與了一項涉及該公司股票的交易。該行動於 2024 年 1 月 29 日進行。但是，公告中尚未披露有關交易性質的細節，例如行動類型、狀態、所涉股票數量、交易價格以及由此產生的所有權。建議投資者尋求更多信息，以充分了解該交易對其投資決策的影響。
Virpax Pharmicals, Inc. [VRPX] 的舉報人傑羅德·森德羅參與了一項涉及該公司股票的交易。該行動於 2024 年 1 月 29 日進行。但是，公告中尚未披露有關交易性質的細節，例如行動類型、狀態、所涉股票數量、交易價格以及由此產生的所有權。建議投資者尋求更多信息，以充分了解該交易對其投資決策的影響。
有用
沒用
